Systemic sclerosis - Diagnosis and classification;Systemische sklerose - Diagnose und klassifikation

Zeitschrift fur Rheumatologie

Volumn 65, Issue 4, 2006, Pages 268-274

  Genth, E ^a,c   Krieg, T ^b  

^a Rheumaklinik und Rheumaforschungsinstitut Aachen ^*  (Germany)

^b UNIVERSITY OF COLOGNE   (Germany)

^c Rheumaklinik und Rheumaforschungsinstitut Aachen   (Germany)

Author keywords

Classification; Criteria; Diagnosis; Scleroderma; Systemic sclerosis (SSc)

Indexed keywords

ANTINUCLEAR ANTIBODY;

ALGORITHM; ANTIBODY DETECTION; BLOOD VESSEL INJURY; CLINICAL EXAMINATION; CLINICAL FEATURE; CLINICAL PRACTICE; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; DISEASE ACTIVITY; DISEASE CLASSIFICATION; EARLY DIAGNOSIS; FIBROSIS; HUMAN; INFLAMMATION; MICROSCOPY; PROGNOSIS; RAYNAUD PHENOMENON; REVIEW; SCLERODERMA; SENSITIVITY AND SPECIFICITY; SYSTEMIC SCLEROSIS; TAXONOMY;

ALGORITHMS; ANTIBODIES, ANTINUCLEAR; DIAGNOSIS, DIFFERENTIAL; HUMANS; MICROSCOPIC ANGIOSCOPY; OUTCOME ASSESSMENT (HEALTH CARE); PROGNOSIS; RAYNAUD DISEASE; SCLERODERMA, SYSTEMIC;

EID: 33746436186     PISSN: 03401855     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00393-006-0065-0     Document Type: Review

References (37)

1. Akesson A, Wollheim FA (1989) Organ manifestations in 100 patients with progressive systemic sclerosis: a comparison between the CREST syndrome and diffuse scleroderma. Br J Rheumatol 28: 281-286
2. Barnett AJ (1978) Scleroderma (progressive systemic sclerosis): progress and course based on a personal series of 118 cases. Med J Aust 2: 129-134
3. Blaszczyk M, Jablonska S, Szymanska-Jagiello W et al. (1991) Childhood scleromyositis: an overlap syndrome associated with PM-Scl antibody. Pediatr Dermatol 8: 1-8
4. Clements PJ, Lachenbruch PA, Ng SC et al. (1990) Skin score. A semiquantitative measure of cutaneous involve ment that improves prediction of prognosis in systemic sclerosis. Arthritis Rheum 33: 1256-1263
5. Cutolo M, Sulli A, Pizzorni C, Accardo S (2000) Nail-fold videocapillaroscopy assessment of microvascular damage in systemic sclerosis. J Rheumatol 27: 155-160
6. Ferri C, Valentini G, Cozzi F et al. (2002) Systemic sclerosis: demographic, clinical, and serologic features and survival in 1,012 Italian patients. Medicine (Baltimore) 81: 139-153
7. Fries JF, Hochberg MC, Medsger TA et al. and ACR Diagnostic and Therapeutic Criteria Committee (1994) Criteria for rheumatic disease. Different types and different functions. Arthritis Rheum 37: 454-462
8. Fritzler MJ, Kinsella TD, Garbutt E (1980) The CREST syndrome: a distinct serologic entity with anticentromere antibodies. Am J Med 69: 520-526
9. Giordano M, Ara M, Capelli L et al. (1976) [Variability of the clinical picture and the classification of progressive systemic scleroderma]. Z Rheumatol 35: 286-300
10. Giordano M, Valentini G, Migliaresi S et al. (1986) Different antibody patterns and different prognoses in patients with scleroderma with various extent of skin sclerosis. J Rheumatol 13: 911-916
11. Hesselstrand R, Scheja A, Shen GQ et al. (2003) The association of antinuclear antibodies with organ involvement and survival in systemic sclerosis. Rheumatology (Oxford) 42: 534-540
12. Holzmann H, Sollberg S, Altmeyer P (1987) [Classification of progressive systemic scleroderma]. Hautarzt 38: 253-257
13. Jacobsen S, Halberg P, Ullman S (1998) Mortality and causes of death of 344 Danish patients with systemic sclerosis (scleroderma). Br J Rheumatol 37: 750-755
14. Kallenberg CG, Wouda AA, Hoet MH et al. (1988) Development of connective tissue disease in patients presenting with Raynaud's phenomenon: a six year follow up with emphasis on the predictive value of antinuclear antibodies as detected by immunoblotting. Ann Rheum Dis 47: 634-641
15. Langaard H (1959) Dysphagia, Raynaud's disease, calcinosis cutis: a nosological entity as expression of scleroderma. Ugeskr Laeger 121: 210-213
16. LeRoy EC, Medsger TA Jr (2001) Criteria for the classification of early systemic sclerosis. J Rheumatol 28: 1573-1576
17. LeRoy EC, Maricq HR, Kahaleh MB (1980) Undifferentiated connective tissue syndromes. Arthritis Rheum 23: 341-343
18. LeRoy EC, Black C, Fleischmajer R et al. (1988) Scleroderma (systemic sclerosis): classification subsets and pathogenesis. J. Rheumatol 15: 202-205
19. Lonzetti LS, Joyal F, Raynauld JP et al. (2001) Updating the American College of Rheumatology preliminary classification criteria for systemic sclerosis: addition of severe nailfold capillaroscopy abnormalities markedly increases the sensitivity for limited scleroderma. Arthritis Rheum 44: 735-736
20. Maricq HR, Valter I (2004) A working classification of scleroderma spectrum disorders: a proposal and the results of testing on a sample of patients. Clin Exp Rheumatol 22: S5-S13
21. Maricq HR, LeRoy EC, D'Angelo WA et al. (1980) Diagnostic potential of in vivo capillary microscopy in scleroderma and related disorders. Arthritis Rheum 23: 183-189
22. Maricq HR, Weinberger AB, LeRoy EC (1982) Early detection of scleroderma-spectrum disorders by in vivo capillary microscopy: a prospective study of patients with Raynaud's phenomenon. J Rheumatol 9: 289-291
23. Masi AT, Rodnan GP, Medsger T et al. (1980) Preliminary criteria for the classification of systemic sclerosis (scleroderma). Arthritis Rheum 23: 581-590
24. Medsger TA Jr, Silman AJ, Steen VD et al.(1999) A disease severity scale for systemic sclerosis: development and testing. J Rheumatol 26: 2159-2167
25. Medsger TA Jr, Bombardieri S, Czirjak L et al. (2003) Assessment of disease severity and prognosis. Clin Exp Rheumatol 21: S42-S46
26. Merkel PA, Clements PJ, Reveille JD et al. (2003) Current status of outcome measure development for clinical trials in systemic sclerosis. Report from OMERACT 6. J Rheumatol 30: 1630-1647
27. Nadashkevich O, Davis P, Fritzler MJ (2004) A proposal of criteria for the classification of systemic sclerosis. Med Sci Monit 10: CR615-CR621
28. Poormoghim H, Lucas M, Fertig N, Medsger TA Jr (2000) Systemic sclerosis sine scleroderma: demographic, clinical, and serologic features and survival in forty-eight patients. Arthritis Rheum 43: 444-451
29. Scussel-Lonzetti L, Joyal F, Raynauld JP et al. (2002) Predicting mortality in systemic sclerosis: analysis of a cohort of 309 French Canadian patients with emphasis on features at diagnosis as predictive factors for survival. Medicine (Baltimore) 81: 154-167
30. Sharp GC, Irvin WS, Tan EM et al. (1972) Mixed connective tissue disease. An apparently distinct rheumatic disease syndrome associated with a specific antibody to an extractable nuclear antigen (ENA). Am J Med 52: 148-159
31. Steen VD (1998) Clinical manifestations of systemic sclerosis. Semin Cutan Med Surg 17: 48-54
32. Tan EM, Rodnan GP, Garcia I et al. (1980) Diversity of antinuclear antibodies in progressive systemic sclerosis. Arthritis Rheum 23: 617-625
33. Tuffanelli DL, Winkelmann RK (1962) Diffuse systemic scleroderma. A comparison with acrosclerosis. Ann Intern Med 57: 198-203
34. Valentini G, Della RA, Bombardieri S et al. (2001) European multicentre study to define disease activity criteria for systemic sclerosis. II. Identification of disease activity variables and development of preliminary activity indexes. Ann Rheum Dis 60: 592-598
35. Valentini G, Bencivelli W, Bombardieri S et al. (2003) European Scleroderma Study Group to define disease activity criteria for systemic sclerosis. III. Assessment of the construct validity of the preliminary activity criteria. Ann Rheum Dis 62: 901-903
36. Weiner ES, Hildebrandt S, Senécal J et al. (1991) Prognostic significance of anticentromere antibodies and antitopoisomerase I antibodies in Raynaud's disease. Arthritis Rheum 34: 68-77
37. Winterbauer RH (1964) Multiple telangiectasia, Raynaud's phenomenon, sclerodactyly, and subcutanious calcinosis: a syndrome mimicking hereditary hemorrhagic telangiectasia. Bull Johns Hopkins Hosp 114: 361-383